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Abstract
This study utilized a novel design to investigate the sensitivity of D2 dopamine receptors
to modulating compounds through multiple exposures over early development of zebrafish
larvae. Zebrafish were dosed for 30 minutes from 5-8 days post fertilization (dpf) with 16µ/mol
of either a D2 antagonist, haloperidol, or a D2 agonist, quinpirole hydrochloride. Two other
groups were then dosed with these compounds from 9-12dpf. The effects of D2 receptor
modulation were measured by analyzing motor activity on measures of movement distance,
frequency, and velocity. Results indicated that larvae dosed with haloperidol on 5dpf had
increased activity after the first dosage, but these differences lessened over days 6-8dpf. While
conversely, the quinpirole group displayed a decrease in movement activity during trials but in
this case, there was a greater deviation from control on trials during 7 and 8dpf. These effects
were not observed in subjects dosed from 9-12dpf, which displayed no significant differences
from control activity, supporting the hypothesis that those dosed earlier in development would
experience greater impacts of D2 modulation. Follow up testing at 16-18dpf did not result in
statistically significant differences across treatments, but there were trends on all three measures
of lower activity in the quinpirole 5-8dpf group and increased levels of activity in the haloperidol
5-8dpf group. Taken together, these results provide further support for use of Danio rerio larval
locomotor activity as a measure of D2 receptor modulation as well as evidence for differential
impacts on dopaminergic activity dependent upon the period of drug administration.
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1. Introduction
1.1. The Dopaminergic System and the D2 Subtype Receptor
The dopaminergic system is essential in the central nervous system’s regulation of
various bodily functions. These include voluntary movement, reward response, addiction
behaviors, mood, cognition, memory, learning, and sleep. Therefore, the balance and
functionality of the dopaminergic system have profound impacts on the physical and mental
health of an individual (Beaulieu & Gainetdinov, 2011). This system has dispersed neuron
populations that operate through a complex network of pathways and receptor subtypes. The
present study focuses primarily on the activity of D2 subtype neurons which have their greatest
populations in the nigrostriatal pathway consisting of diverse brain regions including the caudate
nucleus, putamen, and substantia nigra see Fig.1.

Fig 1. The Dopaminergic System; Regions of Interest: Nigrostriatal pathway, Caudate Nucleus, Putamen Dorsal
Striatum, Substantia Nigra, Cerebellum (Lynch & Jaffe, 2007).

The activity and functionality of these pathways is modulated by the exogenous levels of
dopamine which circulate between synapses. These exogenous levels which filter throughout the
nervous system are regulated by both phasic and tonic modes of transmission (Grace, 1991). The
phasic release of dopamine is produced through exocytosis in which a neuron’s electrical
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gradient is pushed to a critical threshold due to an acute response to external stimuli. This results
in the release of dopamine stored within the synaptic vesicle of dopaminergic cells. These
dopamine molecules then pass through the synaptic gap to bind to a neighboring neuron which
initiates activation and communication of dopaminergic G-protein coupled receptors (GPCRs).
Activation of these receptors occurs when a ligand, in this case, dopamine, binds with the
extracellular surface of the GPCR causing a conformational change and the subsequent release of
G-proteins which have differential actions dependent on cell type and external stimuli. In the
case of the D2 dopamine receptor, the focus of the present study, there are linked inhibitory
G-proteins which activate through inhibiting the enzyme adenylate cyclase and subsequently, this
modulates the activity of several critical cellular pathways such as the P13k-Akt signaling
transduction pathway (Beaulieu & Gainetdinov, 2011).

Fig 2. Cross-section of D2 Dopamine G-Protein Coupled Receptor Activation: 1. Ligand binds to the extracellular
receptor site of the GPCR (on the left) 2. Leads to conformational change and release of G-protein subunits 3.
G-proteins inhibit Adenylate Cyclase allowing downstream activity to initiate (Pescosolido, et al., 2013).
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In contrast to the responsive nature of phasic transmission, there is also importantly a
tonic transmission of dopamine, a constant “background” release from the frontal cortex into
extracellular space between neurons. This tonic transmission has been proposed to regulate the
intensity of phasic response and therefore modulation of exogenous dopamine levels would
therefore affect the sensitivity and function of dopamine receptors (Grace, 1991). This is of
relevance to the present study as previous research has suggested that tonic transmission is
regulated through coactivation of the D1 and the D2 receptor (Money & Stanwood, 2013). This
would indicate that modulation of D2 receptor activity may have consequences on both
D2-specific cellular pathways and the regulation of tonic dopamine transmission to the
dopaminergic system as a whole. This may further imply that the activity of the dopaminergic
transmission as a whole can be modulated by the presence of external compounds from
environmental and pharmacological influences which are able to bind to D2 G-protein coupled
receptors. Two methods of action for such compounds are antagonism and agonism. An
antagonist compound binds with the postsynaptic membrane of a GPCR in place of the
endogenous neurotransmitter without causing the subsequent conformational release of
G-protein subunits and thus inhibits the proper activation of the receptor. Conversely, the binding
of an agonist to the receptor site does initiate G-protein inhibition, resulting in an increase in
activity of the stimulated receptor. The D2 receptor has also been implicated in a variety of
critical cellular and neurological processes downstream of activation (Souza et al., 2011; Ek et
al., 2012), and several mutations of associated genes have been linked to atypical dopamine
receptor signaling (Nerenz 2018). Furthermore, other studies have found an association between
this deregulation in dopaminergic activity and the development of various neurological disorders.
In order to investigate the potential sensitivity of these receptors to modulation from in utero and
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neonatal influences, the present study administered Danio rerio larvae with either a D2
antagonist, haloperidol or a D2 agonist, quinpirole to observe the downstream locomotor effects.
1.2. The PI3K/Akt Pathway and GABAergic Deregulation
For decades the field of neuroscience has found associations between abnormal dopamine
signaling primarily and certain neurological disorders. Recently, a possible explanation of this
trend has been discovered as there appears to be a link between the activity of the D2 receptor
and the abundance of the protein kinase Akt, a reduction of which is typical in schizophrenic
patients (Lai et al., 2006; Beaulieu et al., 2007; Tan et al., 2008). The downstream activity of
adenylate cyclase inhibition subsequently initiates the Akt pathway through a complex formation
with beta-arrestin and PP2A proteins (Bealieu et al., 2007) as illustrated in Fig. 3. This complex
inhibits phosphorylation of Akt and after a series of signaling cascades the Akt protein is
translocated to the cytoplasm and nucleus of the cell where it can activate the GSK3 protein
leading to a range of cellular functions with critical downstream effects on other aspects of the
nervous (Brazil & Hemmings, 2001). These include gene transcription, cell proliferation, and
neuronal migration. Therefore, it is postulated that dysregulation of dopamine signaling and
subsequently the Akt protein may lead to malformation of neuronal circuitry and functionality.
The present study aims to measure this D2 and Akt deregulation through locomotor activity due
to previous implications of a connection between D2 modulation and GABAergic transmission,
but the level of sensitivity and extent of consequences have yet to be fully elucidated (Souza et
al., 2011; Irons et al., 2013; Nabinger et al., 2021).
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Fig 3. Schematic of Akt Pathway activation: 1. Inhibition of adenylate cyclase initiates further 2. G protein signaling
leading to complex formation of βarrestin2 and PP2A 3. Akt pathway activates GSK3 protein leading to regulation
of GABAergic system (Beaulieu, et al., 2011).

Utilizing zebrafish larvae as a model, one team observed that through the agonism of D2
receptors the production of Atk will decrease due to a reduction in the precursor compound pAkt.
They observed that this suppression of Akt activity subsequently caused a significant decrease in
the GABAergic neuron population in the brain and thus led to dysregulation of locomotor
behavior (Souza, Romano-Silva, & Tropepe; 2011). The team further observed that a reduction
of endogenous dopamine increases movement initiation when the GABAergic system is
functional. They then tested whether this relationship was apparent in the opposite direction by
reducing the number of GABAergic neurons which, regardless of dopamine levels, caused a
significant decrease in initiations of movement. Taken together this suggests that dopamine
negatively regulates GABA to control movement behavior and that the GABAergic system is
downstream of the dopaminergic in motor regulation. This analysis of zebrafish locomotor
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behavior during early development demonstrated evidence of a complex interaction between D2
activation and locomotor activity essential for the current study (Souza, Romano-Silva, &
Tropepe; 2011). Taking these previous findings together, the apparent locomotor abnormalities of
animal subjects can be traced to the downstream effects of D2 receptor modulation through the
Akt pathway; and suggests that differences in motor development are indicative of not only
deregulation in the dopaminergic system, but also a decrease in expression of certain genes, and
the functionality of cell cycle regulation (Beaulieu et al., 2007; Brown et al.,2012; Lai et al.,
2006; Laing et al., 2020).
1.3. History of Antipsychotics and D2-Linked Disorders
The primary area of D2 research, beginning in the 1960s, has been in the effort of
pharmaceutical treatment for psychotic conditions, primarily schizophrenia (Bilder et al., 2000;
Brown et al., 2012; Kapur et al., 2000). The first antipsychotic medications to be developed, such
as haloperidol and loxapine, known as typical antipsychotics, act on the D2 receptor through
antagonism resulting in a reduction of D2 activity associated with relief from psychotic
symptoms. However, these medications have also displayed a great deal of adverse effects
primarily in regards to motor disorders. Due to these apparent risks these drugs are now
secondary to atypical antipsychotics in treatment primarily Clozapine, Risperidone, and
Olanzapine (Armenteros & Davies, 2006). Unfortunately, these medications can also have severe
side effects including neutropenia in which the nervous system has an extreme reduction in white
blood cell count (Kumra et al., 2008). In addition, research has suggested that the susceptibility
of this condition is far greater in children and varies across race, sex, and age (Maher et al.,
2013). Furthermore, the research regarding whether typical or atypical antipsychotics have a
greater effect on reducing symptomatology has been inconclusive (Gurevich et al., 2012).
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The antipsychotics which are known to cause Parkinsonism, including haloperidol have
been shown to bind more tightly to the D2 receptors than atypical antipsychotics which have not
been known to cause Parkinsonism. However, this is counterbalanced by shorter-acting relief
from psychotic symptoms (Kapur et al., 2000; Seeman & Tallireco, 1998). Therefore, individuals
suffering from psychosis are forced to choose between less effective medication or more severe
side effects. This is especially important for some patients who only display any
symptomatology improvement when using the more tightly bound drugs (de Haan et al., 2003).
Research has also displayed a significant correlation between increased D2 receptor occupancy
and an increase in clinical improvement. These effects also increased significantly past 65% D2
receptor occupancy (Kapur et al, 2000). This is a serious issue in regards to antipsychotic
treatment as other studies have shown that some patients with severe psychosis only experience
noticeable relief with D2 occupancy of 60-75% (de Haan et al., 2003). Despite the current
understanding of these dangers, the use of both typical and atypical antipsychotics has remained
one of few methods in the treatment of both adult and childhood-onset schizophrenia
(Armenteros & Davies, 2006; Bartlett, 2013; Gurevich et al., 2012; Sikich et al., 2008).
In recent years, the D2 receptor has also been implicated in a variety of other
neurological disorders. For instance, the root of dysfunction in Parkinson's patients has been
traced to a reduction in the level of dopaminergic neurons within the striatum mediated by the
D2, which leads to the subsequent dysfunction of the thalamus. Further supporting this is
evidence that restoration of dopamine activity in the striatum through D1 and D2 activation can
alleviate the lack of motor control in Parkinson’s patients (DeMaagda & Phillip, 2015). Research
has also correlated genes involved in the neurotransmission of dopamine with ADHD (Sachs et
al., 2000; Sobel et al., 2010). In particular, a higher level of dopamine transporter gene has been
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associated with the presence of ADHD symptomatology. This has been theorized to lead to a
reduction of synaptic dopamine levels which subsequently alters neurological morphology. As a
possible explanation, studies of the basal ganglia in both animal models and humans have
suggested a link between a deficit of dopamine concentration in the basal ganglia and a reduction
in number of synapses and a decrease in dendritic spine volume and length (Sobel et al., 2010).
Lastly, the D2 receptor is essential for the maintenance of and proper functioning of several
frontal cortical areas in the aging brain (Money & Stanwood, 2013). Findings have indicated that
a reduction in the distribution of the D2 receptor and an age-related decline in dopamine activity
with impairment in frontal and cingulate metabolism leads to difficulties in both motor and
cognitive function of elderly subjects including neurodegenerative conditions such as
Alzheimer’s (Kemppainen et al., 2003; Volkow et al., 1999). This reduction of dopaminergic
function has also displayed symptomatology remarkably similar to psychosis that is
characteristic of schizophrenia further underlining the D2 receptor as the root of dysfunction
(Howard et al., 2000; Jeste et al., 2000). This current body of research on neurological disorders
linked to deregulation of D2 receptor activity calls for further investigation of susceptibility to
receptor modulation in early development. Further evidence and understanding of this interaction
will help to elucidate the progression of numerous neurological disorders. In this effort, the
present study analyzed the effects of both haloperidol and quinpirole on larval locomotor
activity.
1.4. Haloperidol
Haloperidol, commonly known as Haldol, is a D2 receptor antagonist which was
synthesized in 1958 by the Belgian laboratories Janssen, and research of its possible clinical
applications began soon thereafter. Within the coming decades, the compound would be selected
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as one of the most powerful antipsychotic medications to date and subsequently became the main
prescription for treating symptoms of schizophrenia (Granger & Albu, 2015). Following this the
compound has been used for the treatment of a variety of general hyperactivity symptoms such
as impulsivity, sustaining attention, aggression, mood lability, and poor frustration tolerance
(Kudo et al., 1999) and more recently, in the treatment of Alzheimer’s and bipolar disorder (Pan
et al., 2019; Ashok et al., 2017). The use of this D2 antagonist, however, has been proven to lead
directly to the development of movement disorders and therefore, can only be used when the
psychosis is severe enough for treatment to be justified (Seeman & Phillip, 2010).
1.5. Quinpirole
Quinpirole hydrochloride is a dopamine agonist that has a high affinity to the D2 subtype.
This compound has displayed the highest levels of binding within the striatum, nucleus
accumbens, and olfactory tubercles, these areas are linked to the progression of several disorders
such as Parkinson’s (Koller et al., 1987). As a result, this agonist has also been proposed as a
treatment for Parkinson’s disease and D2 antagonist induced tardive dyskinesia. This has been
further supported by trials indicating the reduction of abnormal movement behavior in a rat
model (Choi & Horner, 2021; Koller et al., 1987). However, multiple studies have also displayed
the ability of repeated daily postnatal quinpirole exposure in rats to lead to an irreversible D2
receptor supersensitivity (Kostrzewa 1995; Kostrzewa et al., 2003). Hippocampal volumes of
brain-derived neurotrophic factor and nerve growth factor were also found to be significantly
reduced along with a decrease in the striatum and frontal cortex gene expression within
quinpirole dosages subjects (Thacker et al. 2006; Maple et al. 2007). This compound has also
been shown to disrupt the Akt pathway and alter locomotor behavior in the zebrafish model in a
number of studies (Nabinger et al., 2021; Souza et al., 2011; Oliveri and Levin, 2019).
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1.6. Danio rerio as a Developmental Model
The use of animals as neurodevelopmental models has been a cornerstone in the fields of
behavioral and neurological research since their founding. Among these models, Danio rerio,
also known as the zebrafish, has risen to prominence in the fields of pharmacology, toxicology,
and neuroscience. This popularity is largely rooted in the practical use of zebrafish larvae is far
more simple, replicable, and inexpensive in comparison to other models as a result of large
breeding clutches, extremely small size, and low maintenance (Basnet et al., 2019; Kalueff et al.,
2014; Nabinger et al., 2021; Stewart et al., 2014). In addition, their life cycle proceeds in an
easily predictable manner and they are capable of breeding from maturation until death. A single
female can lay hundreds of eggs each week and the embryos are developed into larvae by 72
hours post-fertilization as seen in Fig 4. These embryos are translucent and the organs of the
zebrafish develop within one day post fertilization (1dpf) which allows for simple monitoring
and manipulation.

Fig 4. Timelapse of Danio rerio development from embryo to larvae over the course of 72 hours (Hendel, 2004).
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Most relevant to the study at hand, this expediency of the central nervous system
development presents the zebrafish as a particular model for translation of developmental
manipulations (Basnet et al., 2019; Kalueff et al., 2014; Nabinger et al., 2021; Stewart et al.,
2014). Furthermore, zebrafish are also known to be sensitive to all major classes of neurotropic
drugs, including antipsychotics, mood stabilizers, anxiolytics, antidepressants, and stimulants.
Due to this sensitivity and rapid development of the central nervous system the zebrafish is an
excellent model for investigating early life drug exposure and the effects this has on subsequent
development and behavior. Prior studies have also observed a variety of developmental
phenotypes both social and behavioral, believed to be linked to the deregulation of dopaminergic
transmission (Dreosti, et al., 2015, Stewart, et al., 2014).
For the present study, this model was selected due to the conservation of relevant cortical
regions and the translatability of neuronal manipulation with humans. In 2001 researchers
successfully analyzed the entire genome and located at least one orthologue, a string of
homologous DNA deriving from a common ancestor, in zebrafish for 71.4% of human genes as
well as at least one human orthologue for 69% of zebrafish genes (Howe.K, et al., 2001). This
research has suggested that despite the apparent evolutionary distance between teleosts and
mammals there is a great deal of homology in the functionality of key brain regions including the
olfactory bulb, cerebellum, spinal cord and habenula which regulates the release of serotonin and
dopamine in the nervous system (Aizawa et al., 2010; Aizawa et al., 2011). Comparisons of these
structures in both central nervous systems can be seen in Fig. 5.
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Fig 5. Comparison of the evolutionarily conserved regions of the dopaminergic system between the zebrafish and
human central nervous systems; Key area of interest: telencephalon and diencephalon (Bartel, et al., 2020).

Studies have also been conducted to discover the genomic sequence specifically for
segments pertaining to D2 receptor genes in the zebrafish model. One team identified several
localized areas which coded for three different D2 subtypes, two of which occurred on the
analogous chromosome in the human genome and they found 70% overall homology of the
receptor between the two species (Bohmler, et al., 2004; Ek 2012). In addition, the neuronal
pathways which are responsible for locomotion in Danio rerio, the reticulospinal neurons, and
descending vestibulospinal projections are evolutionarily conserved among vertebrates (Basnet
et al., 2019; Du et al., 2016; Kunst et al., 2019). The dorsal and ventral nuclei of the teleostean
ventral telencephalic area are also believed to be analogous to the striatum and septum of other
vertebrates (Wulliman & Rink, 2002). Lastly, the development of the dopaminergic system in
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zebrafish begins around 15-18hpf and the entire system including neuronal projections are fully
established by the end of 4dpf (Boehmler et al., 2004; Stickney et al., 2014). Therefore, both the
analogous nature and rapid growth of the dopaminergic system in zebrafish present it as an
extremely useful neurodevelopmental model for the present investigation of D2 receptor
modulation.
1.7. Rationale for Study
While the sensitivity of the dopaminergic system has become clearer, concerns about
early life damage and subsequent outcomes have become increasingly important because this
system is linked to the onset of several prevalent neurological disorders. Among the greatest
risks for this type of early developmental damage in humans is intrauterine drug exposure (Bell
& Lau, 1995; Julvez & Grandjean, 2009; Kwong & Ryan, 1997). However, the majority of
studies investigating this issue have focused on drug abuse of illegal substances while little has
been done in comparison to elucidate the interactions of prescribed pharmaceuticals (BjørlingPoulsen, 2008; Ross et al., 2015). For instance, the influence of cocaine in utero has been
associated with both increase in premature labor and a variety of developmental delays such as
microcephaly, cardiac and genitourinary abnormalities, and central nervous system stroke
(Young & Phillips, 1992). This is noteworthy considering the main region of effect under the
influence of cocaine is in dopaminergic transmission which underlies the mechanisms of action
in pharmaceuticals including antipsychotic medication which is used in treating a variety of
disorders. One of few meta-analyses on the neurodevelopmental consequences linked to
intrauterine exposure of antipsychotics found significant effects of dopaminergic dysfunction in
the case of animal models, but less substantial evidence in humans (Poels et al., 2018). These
developmental issues in animal studies are exemplified through decreased brain weight, lack of
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certain neurocircuit communications, as well as behavioral changes characterized by avoidance
and anxiety-like phenotypes (Basnet et al., 2019, Du et al., 2016, Souza & Tropepe, 2011).
Despite less evidence of effects in humans, these findings remain relevant as these changes in
animal models occur along the same evolutionarily conserved pathways as human neurological
disorders such as Parkinson’s disease and schizophrenia (Howe.K, et al., 2001; Aizawa et al.,
2010; Aizawa et al., 2011). Therefore, given the current lack of understanding in the field, it is
critical to gain greater knowledge of the long-term effects of D2 receptor modulation. The
present study utilized the zebrafish as a neurodevelopmental model in order to investigate the
early developmental effects of this D2 modulation through administration of either a D2
antagonist, haloperidol, or a D2 agonist, quinpirole.
1.8. Hypotheses
Given the current literature on D2 modulation and subsequent downstream effects, the
present study had three separate hypotheses to investigate different aspects of developmental
effects. Firstly, both groups of larvae dosed with haloperidol from 5-8dpf and 9-12dpf would
exhibit increased activity on measures of movement distance, movement frequency, and average
velocity from control subjects while groups dosed with quinpirole would exhibit decreased
activity from the control. Secondly, larvae dosed from 5-8dpf would display more significant
differences from the control over the period of testing than their counterparts dosed from
9-12dpf. And lastly, during follow up trials from 16-20dpf groups dosed from dpf5-dpf8 would
exhibit more significant variations in movement activity from the control than their counterparts
that were dosed from 9dpf-12dpf.
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2. Methods
2.1. Study Design and Procedure
Beginning on 5dpf two groups of 15 zebrafish larvae were dosed for half an hour with
16µ/mol D2 modulating compounds, group one with haloperidol, a D2 antagonist, and group two
with quinpirole, a D2 agonist. After this half-hour dosing period, four subjects from each group
along with four control subjects were placed into individual arenas of a 3x4 well plate
(Appendix. B.). These well plates were then tracked and movement activity was analyzed over
the course of four ten-minute trials. Afterward all subjects were returned to their original Petri
dishes with EW solution. This procedure was then repeated over the next three days from 6-8dpf.
Following 8dpf these two groups were no longer administered. On 9dpf two new groups of
larvae that had not previously been dosed underwent an analogous procedure to those dosed from
5-8dpf. These groups were then dosed over 10-12dpf. This study design provided these four
experimental groups to investigate differential motor behaviors modulated by both the drug
method of action and period of drug administration. Following final drug administration on
12dpf all groups were cared for in preparation for follow up testing from 16-20dpf. However, in
the present study, there was an unexpectedly high death rate in the haloperidol 5-8dpf group, and
as a result data collection only occurred on 16 and 17dpf. These follow up tests were identical to
previous data collection with the exception of no further drug dosing. The drug administration
and euthanasia protocol used in this design was approved by the Bard College IACUC.

Fig. 6 Table laying out the 2x2 design of the four treatment groups utilized in the present study
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2.2. Fish Husbandry
Approximately 100 zebrafish embryos were produced from TU wild-type zebrafish and
remained in a controlled environment until 4dpf wherein they were transferred to the testing site
and separated into six groups of 15 subjects (4 experimental groups and 2 control groups). Here
they were housed inside an incubator set at 28℃. For the first three days, the larvae received
nutrients from an egg water (EW) solution designed for their early development. This EW is a
solution of deionized water with concentrations of 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4, and 10-5 % Methylene Blue. Proper concentrations were gained by diluting a
stock solution. Beginning on 4dpf, larvae were cared for twice a day first at 9:00 am and 5:00
pm, each petri dish was cleaned, EW solution was replaced and the larvae were given a small
amount of micron fish food.
2.3. Drug Administration
Starting from 5dpf both the 5dpf-8dpf groups were dosed for half an hour (from
approximately 3:30-4:00 pm) with 16µ/mol of haloperidol and quinpirole respectively which
were ordered from Sigma-Aldrich Inc. (ST. Louis, MO). Dosing of 16µ/mol of haloperidol and
quinpirole was based on the findings by Irons et al., 2013 that displayed the most significant
movement results at this dose as opposed to higher or lower concentrations. The drug stock
solution of haloperidol was created by first mixing 8mL of dimethyl sulfoxide into 40 mL of EW
and dissolving 12.8mg of haloperidol into the mixture. For dosing 1mL of this stock was added
to 49mL of EW and subjects were then placed in the solution for 30 minutes. The duration of
dosage was determined by previous studies and results from Pilot Study 1 (see Appendix. T.).
The drug stock solution for quinpirole was made by dissolving 6.8mg of the drug into 16mL of
EW. For dosing 500 micro/mol of stock was placed into 49.5 mL of EW to gain the proper
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concentration. This procedure was repeated from days 5 through 8 after which the 9dpf-12dpf
groups underwent an analogous procedure for the next 4 days. Following the final drug dosing
on 12dpf, larvae were maintained and cared for until 16dpf wherein locomotor tests resumed.
Larvae’s locomotor activity was analyzed once again from 16-18dpf the previous procedure but
without further drug administration.
2.4. Locomotor Data Collection
For each test 12 subjects were placed in a 4x3 well-plate, 4 controls, 4 treated with
haloperidol, and 4 treated with quinpirole. The arenas were placed inside of the DanioVision™
lightbox (Noldus Information Technology, Wageningen, the Netherlands) and their movement
was tracked and analyzed using the EthoVision XT® tracking software (Noldus Information
Technology, Wageningen, the Netherlands). Inside the lightbox, an infrared camera selects for
each of the 12 subjects and tracks their locomotor activity across 40 minutes segmented into four
10-minute trials. The EthoVision XT® software then receives this input and records data every
few milliseconds. Following data collection, each trial was exported to Microsoft Excel where all
the data gathered over the trial for each subject is presented in a spreadsheet. This raw movement
data was then organized in order to calculate the movement behavior of each subject per
10-minute trial, from this data total distance moved in cm, average velocity, and movement
frequency were calculated for each subject across all conditions. Decisions on the duration of
trials and measurements of locomotor activity were based on findings from pilot studies 2 and 3
(See Appendix. U. & V.).
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2.5. Statistical Analysis
Statistical comparisons were performed through a series of two-way repeated measures
ANOVAs on measurements of total movement distance in cm, velocity cm/s, and movement
frequency (number of total movement initiations over trial) through Jamovi statistical software
(Jamovi Project, Sydney Australia). This analysis implemented a two-way 3x4 repeated
measures ANOVA in order to compare differences among groups on both the between-subjects
factor of “Treatment” with the factors “Control, Haloperidol, and Quinpirole” and the
within-subjects factor of “Trial” with factors of “Trial 1, Trial 2, Trial 3 and Trial 4”. Separate
ANOVAs of this design were performed for movement measures of distance, frequency, and
velocity for each day of testing. These tests represent four trials with four subjects in each of the
three treatments. However, due to the nature of the zebrafish model, it is difficult to distinguish
between individual subjects and so repeated measures analysis over multiple days of testing was
not viable for this experiment.

EFFECTS OF D2 MODULATION ON DANIO RERIO MOTOR DEVELOPMENT

22

3. Results
3.1. Trials From 5-8dpf
5dpf Distance
Results of trials recorded on 5dpf directly following the first drug administration
provided evidence of D2 antagonism leading to an increase in the movement behavior of larvae
on measures of total distance, movement frequency, and average velocity. A two-way repeated
measures ANOVA of the data recorded on 5dpf presented both a main effect of trial on 5dpf F(3,
27) = 67.02, p= <.001 along with an interaction of trial and treatment F(6,27) = 4.09, p= .005.

Fig. 7 Distance moved on trial 1 had little variance, but during trials 2 and 3, the haloperidol drastically increased in
total distance in a significantly different pattern from both control and quinpirole subjects. Though activity lessened
on trial 4 it was still higher than both other groups; SEs included in Appendix. C.

A post hoc analysis comparing differences between trials displayed significant effects of
higher scores during later trials. This can be seen in comparisons of results on Trial 1(M=112,
SD=28.7) with Trial 2 (M=258, SD=59.2)t(9) = -13.584, p= <.001, on Trial 1 (M=112, SD=28.7)
with Trial 3 (M=256, SD=79.5)t(9) = -11.199, p= <.001 and again between Trial 1 (M=112,
SD=28.7) and Trial 4 (M=209, SD=60.8)t(9) = -6.722, p= <.001. Further analysis also revealed
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that this main effect of trial was largely due to the interaction with treatment and in particular the
activity of the haloperidol dosed larvae. Post hoc tests comparing scores of haloperidol dosed
subjects between trials confirmed this, firstly activity on Hal Trial 1(M=119, SD=36.2) with Hal
Trial 2 (M=298, SD=85.5) t(9) = -9.06, p= <.001, on Hal Trial 1(M=119, SD=36.2) with Hal
Trial 3(M=339, SD=44.1) t(9) = -9.79, p= <.001, and on Hal Trial 1(M=119, SD=36.2) with Hal
Trial 4(M=253, SD=90.6)t(9) = -5.33, p= .012, all provided significant results. Neither of the
other groups displayed any significant post hoc effects. This confirms that the control and
quinpirole treated larvae displayed little variance across the four trials while the haloperidol
group had significant increases over the course of both Trial 2 and 3; this is illustrated in Fig. 7.
5dpf Frequency
The results for 5dpf on the measure of movement frequency provided further evidence of
the D2 altering locomotor activity. Analysis indicated a main effect of trial F(3,27) = 5.77, p =
.003, an interaction of trial and treatment F(6,27) = 4.87, p= .002, and a between subjects main
effect of treatment F(2,9) = 5.7, p= .0025. Post hoc testing further confirmed that movement of
the haloperidol group was significantly different from both control and quinpirole dosed groups
Hal (M=123, SD= 112.75) and control (M=13.5, SD=15.04)t(9) = 2.91, p= .042, Hal (M=123,
SD=112.75) and Quin (M=12.5, SD=12.88) t(9) = -2.93, p= .04. Tests of the interaction between
trial and treatment also revealed a significant result of changes in the haloperidol dosed group
across trials Hal Trial 1(M=34.5, SD=27.4) and Hal Trial 2(M=148, SD=103)t(9) =-4.29, p=
.046, Hal Trial 1(M=34.5, SD=27.4) and Hal Trial 3 (M=211, SD=141) t(9) = -5.148, p= .016.
Thus, confirming that changes in movement frequency occurred in a similar pattern across trials
as the results on distance. All three groups displayed similar results on trial 1 followed by
haloperidol subjects sharply increasing in movement activity during trials 2 and 3.
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Fig 8. Frequency of movement initiations across trials recorded on 5dpf display a significant difference in activity of
the haloperidol dosed larvae with both the control and quinpirole dosed subjects. Similarly to scores of total
distance, the frequency increased significantly during Trial 2 and 3; SEs included in Appendix. D.

5dpf Velocity
Similarly to measures of distance and frequency the results of average velocity on 5dpf
displayed both a main effect of trial on 5dpf F(3,27) = 5.55, p= .004 and an interaction of trial
with treatment F(6,27) = 2.79, p= .031.

Fig 9. Results of the average velocity across trials recorded on 5dpf similarly displayed an increase of activity in
haloperidol-dosed subjects during Trials 2 and 3; SEs in Appendix. E.
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Post-hoc analysis revealed that the increases in velocity of the haloperidol group were not
statistically significant from the control, but it is important to note that the pattern is similar to
the other two measures as illustrated in Fig. 9.
6-7dpf Distance
On days 6 and 7 there were only main effects of trial and no significant interactions , 6dpf
F(3,27)= 3.03, p= .046, and 7dpf F(3,27) = 4.841, p= .008. While there were no significant
interactions or effects of treatment there were trends suggesting a decreased activity in quinpirole
subjects during trials on 6 and 7dpf in similar patterns to frequency as seen in Fig. 10.
6-8dpf Frequency
Similarly to the measure of distance, there were no significant effects on day 6 and on
day 7 there was only a main effect on trial F(2,9) = 4.47, p= .01. After removing three outlier
scores from control scores on 7dpf there was a significant between-subjects effect of treatment
F(2,9) = 5.73, p= .029 and a post hoc showed a significant difference between control (M= 214 ,
SD= 176.75) and quinpirole treated larvae (M=16.37, SD= 12.65) t(7) = 3. 837, p= .015, as well
as between haloperidol (M= 202, SD= 146) and quinpirole (M=16.37, SD= 12.65) t(7) = 3.5, p=
.024, treated subjects. These results are illustrated in Fig. 10. Together these findings from
6-8dpf provide evidence that quinpirole-dosed subjects exhibited lower activity due to D2
modulation during 6 and 7dpf. In addition, considering the significance of haloperidol activity in
5dpf trials the lack of such effects on subsequent testing may be indicative of increased
resistance to antagonism over multiple drug administrations.
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Fig. 10 Results of movement frequency on 7dpf display a significantly lower amount of movement initiations in
comparison to both control and haloperidol-dosed subjects. Outliers included in figure; SEs in Appendix. F.

There were also no significant results of velocity over 6-8dpf displayed no significant effects and
there were none on any measure during trials on 8dpf.
3.2. Trials From 9-12dpf
9dpf Distance
Larvae dosed for the first time on 9dpf displayed a main effect for trial F(3,27) = 18.422,
p= < .001, but in this case, had no interaction with treatment, and all subjects displayed similar
movement patterns and increases across trials as seen in Fig. 11. While there were main effects
of trial, post hoc analysis revealed no relationship with treatment. This differential response of
haloperidol treated subjects from the 5-8dpf counterparts supports the present study’s hypothesis
for greater sensitivity to modulation in the larvae dosed from 5-8dpf.
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Fig 11. Results of the total distance moved across all trials displayed no significant differences between groups and a
similar pattern of increasing activity as trials progressed; SEs in Appendix. G.

9dpf Frequency
Larvae dosed on 9dpf displayed a main effect of trial on the measures of frequency
F(3,27) = 18.173 , p= < .001, however, there was no interaction with treatment. In conjunction
with results of distance moved this suggests that larvae treated on 9dpf exhibited locomotor
activity similar to control subjects. In addition, there were no significant effects of velocity on
9dpf. While larvae dosed with haloperidol on 5dpf exhibited significant variation on all three
measures their counterparts first dosed on 9dpf had movement patterns which had no significant
variations from control subjects.
10-12dpf Activity
On days 10-12dpf the control groups exhibited higher activity on all three measures while
both treated groups displayed similar patterns. There were no significant effects on movement
behavior related to treatment until 12dpf where Interaction of trial and treatment on all three
measurements, distance: F(6,27) = 4.74, p= .018, frequency: F(6,27) = 2.87, p= .027, and
velocity F(6,27) =4.91, p= .002. However, unlike the interactions observed on 5dpf this
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interaction resulted from the control group scoring significantly higher than both drug-dosed
groups. Overall, there were more significant variations in the 5-8dpf groups especially in regard
to the haloperidol 5-8dpf group on the first day of dosing which may indicate a higher level of
D2 receptor sensitivity during earlier stages of development.
3.3. Trials From 16-17dpf
Data collected on both 16 and 17dpf did not provide significant differences between
subjects on any of the three measures. However, trends in this data do provide some evidence of
differential patterns in motor activity. The most apparent trend was a lower level of activity in
larvae dosed with quinpirole on 5-8dpf in comparison with all other subjects across all three
measures. Though less consistent there also appears to be a trend of higher activity in larvae
dosed with haloperidol during 5-8dpf. In addition, both 9-12dpf groups continued to display
lower levels of activity compared to control subjects just as in trials conducted from 10-12dpf
suggested. While results were non-significant these trends were in line with the hypothesis that
differential long-term effects are dependent upon age of dosing. Figures representing data
collected from these trials are included in the appendix of this study.
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4. Discussion
4.1. General Discussion
On 5dpf, the first day of drug administration, larvae in the haloperidol treated group
displayed significant increases in movement activity of larvae dosed with haloperidol over the
course of the four trials while the control and the quinpirole group remained consistent. While all
three groups displayed similar results on trial 1 followed by haloperidol sharply increasing. This
relationship was observed on all measures and most significantly on movement frequency.
Furthermore, results displayed increases in distance and frequency occurring in conjunction with
one another throughout trials which further supports evidence of D2 modulation. This is also
supported by the scores on velocity which display an increase in average velocity in a similar
pattern. Thus, there is significant evidence that on 5dpf the haloperidol treated group’s behavior
was affected by drug treatment. Additionally, in consideration of previous evidence that D2
modulation disrupts the dopamine system’s regulation of GABAergic activity, it is postulated
that more distance traveled in larvae dosed with haloperidol is indicative of the increase in
movement initiations themselves and therefore could suggest Parkinson-like motor deregulation.
The effects of D2 modulation over the course of 6-8dpf were less apparent, nonetheless,
some interesting trends were observed. Firstly, on 6dpf though not significant there was a higher
level of activity of the haloperidol dosed group on measures of distance moved and frequency.
Furthermore, there was a significant decrease in movement initiations of quinpirole dosed
subjects on 6dpf. Then on 7dpf the pattern of results changed to reflect similar movement
activity in control subjects as those doesd with haloperidol while the quinpirole group displayed
lower movement distance and frequency. On 8dpf yet another differential pattern emerged in
which both the haloperidol and quinpirole groups displayed less activity than the control. These
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differences may be due to the individual differences in subjects tested across days of dosing.
Though there were no significant effects of treatment from 6-8dpf, the distance moved across
these four days of testing does display a consistent trend of higher activity in the group dosed
with haloperidol. In addition, larvae in the quinpirole group exhibited little differences from
control at the beginning of dosing, but appear to decrease in activity in the last two tests on 7 and
8dpf. Thus, the results of this study support the hypothesis that D2 modulation would have
inverse effects dependent on the type of D2 binding compound administered. Importantly, these
results display significant differences on 5dpf with non-significant trends over the next three
days of dosing. This may suggest that the dopamine system at 5dpf has either become stable
enough to resist changes in signaling or has adapted to administration of these specific
compounds. Alternatively, this could suggest that the dosage used in this procedure was minimal
enough for the system to adapt to the modulation.
While larvae dosed with haloperidol on 5dpf exhibited significant increases in activity
there was no such effect in those first dosed on 9dpf. Rather, the larvae dosed on 9dpf exhibited
similar movement activity to control subjects on all measures. This suggests that at 9dpf
modulation of D2 receptors did not alter the dopamine system significantly enough to affect
motor behavior. During subsequent tests from 10-12dpf treated groups displayed some
differences from the control group, but in a different pattern than the 5-8dpf subjects. In this
case, both haloperidol and quinpirole groups displayed gradually increasing differences from
control, but not from one another. Essentially, the larvae dosed from 9-12dpf did not exhibit
significant differences from the control, and differences that did arise followed no apparent
pattern. In sum, the data recorded from these four experimental groups provided support for the
hypothesis that those dosed during the earlier period of 5-8dpf would experience more
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significant effects of dosage, but did not elucidate whether this had long-term effects on motor
behavior.
To test this final hypothesis, there was a planned third round of data collection of all
subjects from 16-20dpf. However, data was only collected on days 16 and 17, instead of the
planned testing until 20dpf, due to an unexpectedly high death rate of the 5-8dpf haloperidol
group. On 18dpf only 3 subjects in the haloperidol 5-8dpf group remained so testing was halted
early. Although data collection ended prematurely, trials recorded on 16 and 17dpf did display
some interesting differences in locomotor activity, particularly in the case of groups dosed from
5-8dpf. There were trends of the haloperidol 5-8 group displaying a slightly higher level of
activity than all other treated subjects on each measure of activity on both 16 and 17dpf.
Alternatively, the quinpirole 5-8 group displayed the lowest scores on movement distance and
velocity across both days. Along with low scores in frequency that were made non-significant by
an unexpected low movement frequency in the haloperidol 9-12dpf group. Though these effects
are non-significant they serve as a preliminary glimpse at possible long-term differences in motor
activity of larvae dosed with D2 modulating compounds.
Taken together, the results of this study provided support for two central hypotheses
firstly, that D2 antagonism and subsequent GABAergic deregulation led to increased activity on
all measures of movement activity, and secondly, that D2 modulation had differential effects on
larvae locomotor behavior dependent on the period of dosage. Results of trials from 5-8dpf
found that haloperidol dosed larvae increased in activity significantly during the first day of
dosing while quinpirole dosed subjects displayed some significant decreases in activity on 7 and
8dpf. In addition, differences in behavioral effects of drug manipulation by the period of dosage
were observed by comparing the acute effects of D2 antagonism on larvae first dosed on 5dpf as
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opposed to those first dosed on 9dpf. While the third hypothesis remains open for future
investigation, the present findings support the continued use of Danio rerio locomotor activity as
a measurement of sensitivity to D2 receptor modulation throughout early development.
4.2. Limitations and Future Directions
Though this novel study provided promising results there were some key limitations to
the design that future research can build on. Firstly, the time-sensitive manner of the procedure
created several constraints to the methodology of the study. For instance, the design was meant
for a larger number of test subjects, however, breeding clutch sizes are unpredictable and this led
to the use of smaller treatment groups than desired. This is a significant limitation not only due to
lowering the sample size of statistical analyses but also because smaller groups of larvae can
experience a significant die-off within the first 20 days post fertilization that this experiment
examined. Such a die off occurred in the group dosed with haloperidol from 5-8dpf and while it
is possible that this high death rate is related to D2 modulation such speculation is outside the
confines of the present study. The other major limitation of the present study is the identification
of individual larvae. As these larvae are essentially identical to the naked eye there was no
reasonable way to assess which individual larvae were selected for testing on a particular day. As
a result, the repeated measures ANOVAs were limited to analyzing comparisons of groups over
the four trials performed on a single day of testing and thus there was a much smaller sample size
for statistical analysis.
A starting point for the improvement of this design would be the use of larger testing
arenas in order to simultaneously analyze a larger sample size. This could then be made more
significant by ensuring that the same individual larvae were analyzed in the same arenas over
multiple days of dosage. Which would allow for a more meaningful comparison of locomotor
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activity over the course of development. In addition, future investigations should assess the
effects of D2 modulation on earlier days of larval development to assess impacts on the
dopaminergic system as in utero influences of D2 modulation in humans may well occur prior to
the full development of this system. Due to the wide ranging-downstream effects of the D2
receptor, this future research may be instrumental in the treatment of conditions including but not
limited to: motor dysfunction, psychosis, and delusion related disorders, neurodegenerative
disorders such as Alzheimer’s, and even some forms of cancer (Seeman & Phillip, 2010;
Weissenrieder et al., 2019).
4.3. Conclusions
While previous studies have confirmed that a relationship between D2 modulation and
locomotor activity exists, the level of system sensitivity and longevity of consequences has yet to
be fully elucidated (Souza et al., 2011; Irons et al., 2013). Many of these studies utilized high
dosages of medications, exceeding 80% occupancy of the D2-receptor sites which cause severe
side effects (Kapur et al., 2000; Du et al., 2016). This prolonged level of exposure has allowed
researchers to reliably determine that behavioral differences which arise can assuredly be linked
to the drug treatment. However, this prolonged exposure is not readily translatable to what
human infants may experience from intrauterine or neonatal influences. In addition, research has
displayed that even a single acute administration of D2 modulating compounds are able to
dysregulate D2 activity and cause a litany of downstream effects (Bealieu et al., 2007; Souza,
Romano-Silva, & Tropepe; 2011). For these reasons, this study aimed to assess how repeated
short exposures of D2 modulating compounds can affect the locomotor behavior of the zebrafish
to better understand how sensitive these receptors are during the early stages of
neurodevelopment. In this effort, the study provided potential evidence of differential effects due
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to D2 modulation dependent upon both method of action and period of dosage. Most
significantly, the results of larvae dosed from 5-8dpf exhibiting greater variation from their
counterparts dosed from 9-12dpf provides support for the future implementation and
improvement of similar study paradigms to further elucidate possible critical periods for the
neurodevelopmental consequences of dopaminergic modulation. Future investigations in this
area of research should also focus on the environmental and pharmacological factors which act
on the D2 receptor as this will be instrumental; in not only understanding the progression and
root of D2-linked disorders but also in promoting the development of new and more beneficial
ligands.
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Appendix. T. Pilot Study 1
This study was the first pilot study of this research aiming to find preliminary evidence of
D2 modulation having an effect on activity. Embryos were cared for in until 5dpf wherein they
were transported to an incubator in the Behavioral Neuroscience lab in Preston Hall. The larvae
were immediately separated into control and treated groups, with eight and six subjects
respectively. After an hour of acclimation, the six treated condition larvae were placed into a
16µ/mol solution of haloperidol for 15 minutes (from approximately 11:35-11:50a.m.).
Following treatment, these six larvae were placed along with six control subjects into a 4x3
well-plate of individual arenas filled with untreated EW water. The arenas were placed inside of
the DanioVision observation chamber and their movement was tracked and analyzed using the
Noldus Ethovision XT software. This dosing and tracking procedure was repeated at the same
time for dpf 6, 7, and 8. On days 18 and 19 post fertilization the subjects were tracked once again
without any drug treatment to assess if differences in movement behavior were observable 10
days after the final drug administration. The results displayed conflicting results as on day 18dpf
the treated group (M=1402.13, SD=267.5) had in comparison to the control (M=982.92,
SD=187.5) a significantly higher level of movement 10 days after final drug administration t(8)
= 2.57, p 0.033. However, the following day at 19dpf the treated group (M=1721.64, SD= 188.2)
did not display the same effect t(8) = .22, p = .82 as the control group (M=1685.64, SD=260.3)
did not differ significantly from the treated group’s movement distance.
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Appendix. U. Pilot Study 2

This study was designed to determine if observable differences in behavior occurred after
drug exposure and assess proper duration of exposure. This was essentially to assess if the
proposed procedure was viable and to practice it. The subjects of this pilot study did not undergo
early stage modulation rather all subjects were in a controlled environment and uniform
environment until 21dpf where upon six of the larvae were placed into a 16µ/mol solution of
haloperidol, three for 15 minutes and three for 30 minutes. This solution was created using a
stock of 12mg Haldol with 8ml of DMSO in 40 mL of EW and then diluted by removing 4mL of
stock and adding 196mL of EW to create the desired 16µ/mol solution which. The dosage was
modeled after the procedure utilized by (Irons et al,, 2013). The movement distance of the treated
larvae in the 30 min group (M=1177.51, SD=163.31) in comparison to control levels
(M=631.32, SD=244.6)were found to be significantly greater, t(22) = 6.16, p = < 0.001. The 15
minute group (M=858.27, SD=226.81) also displayed an increased level of movement t(16) =
3.24, p = 0.005) from controls (M=537.02, SD=165). The greater significance of the 30 min
dosage led to the decision to use this dosage in the final experiment to more reliably link
behavioral differences to D2 modulation.
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Appendix. V. Pilot Study 3

The third pilot study was conducted to test the experimental design and determine if there
were any flaws with the procedure. The embryos were bred inside and remained there until 4dpf
wherein they were transferred and separated into six groups of 15 subjects (4 experimental
groups and 2 control groups). The following day subjects from both 5dpf-8dpf groups were
dosed for a half an hour with 16µ/mol of haloperidol and quinpirole respectively. During this
procedure the haloperidol group was dosed from approximately 11:30pm to 12:00pm and were
tested for locomotor behavior in the DanioVision lightbox with six treated and 6 control subjects.
The quinpirole 5dpf- 8dpf group was also then dosed from approximately 12:00pm to 12:30pm
and tested afterwards, again with 6 treated and 6 control. This procedure was repeated from days
5 through 8 after which the 9dpf-12dpf groups underwent an analogous procedure for the next 4
days. Following the final drug administration the larvae were maintained and cared for for the
next 11 days. Unfortunately, several experimental groups had a significant die off near the end of
this period and thus, the data gathered post drug administrations is sparse. While this study was
unsuccessful it served to polish the final study’s experimental design.

